BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mandalakas AM, van Wyk S, Kirchner HL, Walzl G, Cotton M, Rabie H, Kriel B, Gie RP, Schaaf HS, Hesseling AC. Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction. Pediatr Infect Dis J 2013;32:e111-8. [PMID: 23190784 DOI: 10.1097/INF.0b013e31827d77b7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 LaCourse SM, Richardson BA, Kinuthia J, Warr AJ, Maleche-Obimbo E, Matemo D, Cranmer LM, Escudero JN, Hawn TR, John-Stewart GC. Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children. BMJ Open 2020;10:e034308. [PMID: 31969368 DOI: 10.1136/bmjopen-2019-034308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sollai S, Galli L, de Martino M, Chiappini E. Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis 2014;14 Suppl 1:S6. [PMID: 24564486 DOI: 10.1186/1471-2334-14-S1-S6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
3 Meier NR, Volken T, Geiger M, Heininger U, Tebruegge M, Ritz N. Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis. Front Pediatr 2019;7:208. [PMID: 31192175 DOI: 10.3389/fped.2019.00208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
4 Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis 2014;14 Suppl 1:S5. [PMID: 24564453 DOI: 10.1186/1471-2334-14-S1-S5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 8.1] [Reference Citation Analysis]
5 Bean HD, Jiménez-Díaz J, Zhu J, Hill JE. Breathprints of model murine bacterial lung infections are linked with immune response. Eur Respir J 2015;45:181-90. [PMID: 25323243 DOI: 10.1183/09031936.00015814] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
6 Tieu HV, Suntarattiwong P, Puthanakit T, Chotpitayasunondh T, Chokephaibulkit K, Sirivichayakul S, Buranapraditkun S, Rungrojrat P, Chomchey N, Tsiouris S, Hammer S, Nandi V, Ananworanich J; Thai TB Px Study Group. Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure. PLoS One 2014;9:e105003. [PMID: 25121513 DOI: 10.1371/journal.pone.0105003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
7 Johnson DF, Malone LL, Zalwango S, Mukisa Oketcho J, Chervenak KA, Thiel B, Mayanja-Kizza H, Stein CM, Boom WH, Lancioni CL; Tuberculosis Research Unit. Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection. PLoS One 2014;9:e96613. [PMID: 24796677 DOI: 10.1371/journal.pone.0096613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
8 Rose W, Kitai I, Kakkar F, Read SE, Behr MA, Bitnun A. Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values. BMC Infect Dis 2014;14:516. [PMID: 25248406 DOI: 10.1186/1471-2334-14-516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
9 Mukherjee A, Lodha R, Kabra SK. Status and Current Role of ‘Interferon Gamma Release Assays’ vs. ‘Tuberculin Skin Testing’ in Diagnosis of Tubercular Disease. Indian J Pediatr 2013;80:334-6. [DOI: 10.1007/s12098-013-0974-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Evangelopoulos D, Whittaker E, Honeyborne I, McHugh TD, Klein N, Shingadia D. Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report. J Med Case Rep 2017;11:52. [PMID: 28236807 DOI: 10.1186/s13256-017-1222-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Chiappini E, Lo Vecchio A, Garazzino S, Marseglia GL, Bernardi F, Castagnola E, Tomà P, Cirillo D, Russo C, Gabiano C, Ciofi D, Losurdo G, Bocchino M, Tortoli E, Tadolini M, Villani A, Guarino A, Esposito S; Italian Pediatric TB Study Group. Recommendations for the diagnosis of pediatric tuberculosis. Eur J Clin Microbiol Infect Dis 2016;35:1-18. [PMID: 26476550 DOI: 10.1007/s10096-015-2507-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
12 Stout JE, Wu Y, Ho CS, Pettit AC, Feng PJ, Katz DJ, Ghosh S, Venkatappa T, Luo R; Tuberculosis Epidemiologic Studies Consortium. Evaluating latent tuberculosis infection diagnostics using latent class analysis. Thorax 2018;73:1062-70. [PMID: 29982223 DOI: 10.1136/thoraxjnl-2018-211715] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ji L, Lou YL, Wu ZX, Jiang JQ, Fan XL, Wang LF, Liu XX, Du P, Yan J, Sun AH. Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province, China. Infect Dis Poverty 2017;6:121. [PMID: 28859694 DOI: 10.1186/s40249-017-0331-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Nolt D, Starke JR. Tuberculosis Infection in Children and Adolescents: Testing and Treatment. Pediatrics 2021;148:e2021054663. [PMID: 34851422 DOI: 10.1542/peds.2021-054663] [Reference Citation Analysis]
15 Lange C, Mandalakas AM, Kalsdorf B, Denkinger CM, Sester M. Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence. Pathog Immun 2016;1:308-29. [PMID: 28217762 DOI: 10.20411/pai.v1i2.173] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
16 Qiu X, Wang H, Tang Y, Su X, Ge L, Qu Y, Mu D. Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis. Ann Med 2020;52:376-85. [PMID: 32700645 DOI: 10.1080/07853890.2020.1800073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, Grewal HM, Hesseling AC. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med 2015;191:820-30. [PMID: 25622087 DOI: 10.1164/rccm.201406-1165OC] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]